Influence on Enterobacter cloacae Metabolism, Cell-Surface Hydrophobicity and Motility of Suprainhibitory Concentrations of Carbapenems

Folia Microbiologica

Volumn 46, Issue 6, 2001, Pages 505-510

  Majtan V ^a   Majtanova L' ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; IMIPENEM; MEROPENEM; THIENAMYCIN DERIVATIVE;

ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; ENTEROBACTER CLOACAE; HUMAN; HYDROPHOBICITY; MOVEMENT (PHYSIOLOGY); PHYSIOLOGY; TIME;

CARBAPENEMS; ENTEROBACTER CLOACAE; HUMANS; HYDROPHOBICITY; IMIPENEM; MOVEMENT; THIENAMYCINS; TIME FACTORS;

EID: 0035753420     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02817993     Document Type: Article

References (38)

1. BARMADA S., KOHLEPP S, LEGGETT J., DWORKIN R., GILBERT D.: Correlation of tobramycin-induced inhibition of protein synthesis with postantibiotic effect in Escherichia coli. Antimicrob.Agents Chemother. 37, 2678-2683 (1993).
2. BLANCO J., ALONSO M.P., GONZALES E.A., BLANCO M., GARABAL J.J.: Virulence factors of bacteremic Escherichia coli with particular reference to production of cytotoxin necrotizing factor (CNF) by P-fimbriate strains. J.Med.Microbiol. 31, 175-183 (1990).
3. BRAGA P.C., DAL SASSO M., MACI S., REGGIO S., PIATTI G.: Influence of subinhibitory concentrations of brodimoprim and trimethoprim on the adhesiveness, hydrophobicity, hemagglutination and motility of Escherichia coli. Chemotherapy 41, 50-58 (1995).
4. BUCKLEY M.M., BROGDEN R.N., BARRADELL L.B., GOA K.L.: Imipenem-cilastatin. A reappraisal of its antibacterial activity, pharmaco-kinetic properties and therapeutic efficacy. Drugs 4, 408-444 (1992).
5. BUSTAMENTE C.J., DRUSANO G.L., TATEM B., STANDIFORD H.C.: Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrob.Agents Chemother. 5, 678-682 (1984).
6. CRAVEN R..C., MONTIE T.C.: Motility and chemotaxis of three strains of Pseudomonas aeruginosa used for virulence studies. Can. J.Microbiol. 27, 458-460 (1981).
7. GOULD I.M., JASON A.C., MILNE K.: Use of Malthus microbial growth analyzer to study the postantibiotics effect of antibiotic. J.Antimicrob.Chemother. 24, 523-531 (1989).
8. GOTTFREDSSON M., ERLENDSDÓTTIR H., KOLKA R., GUDMUNDSSON A., GUDMUNDSSON S.: Ultrastructural alterations of bacteria during the postantibiotic effect. J.Chemother. 39, 153-162 (1993).
9. GOTTFREDSSON M., ERLENDSDÓTTIR H., GUDMUNDSSON A., GUDMUNDSSON S.: Different patterns of bacterial DNA synthesis during postantibiotic effect. Antimicrob.Agents Chemother. 39, 1314-1319 (1995).
10. GUAN L., BURNHAM J.C.: Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and hemolysin activity. J.Antimicrob.Chemother. 29, 529-538 (1992).
11. GUAN L., BLUMENTHAL R.M., BURNHAM J.C.: Analysis of macromolecular biosynthesis to define the quinolone-induced postantibiotic effect in Escherichia coli. Antimicrob.Agents Chemother. 36, 2118-2124 (1992).
12. HANBERGER H., SVENSSON E., NILSSON L.E., NILSSON M.: Control-related effective regrowth time and post-antibiotic effect of meropenem on Gram-negative bacteria studied by bioluminiscence and viable evants. J.Antimicrob.Chemother. 35, 585-592 (1995).
13. HORGEN L., JEROME A., RASTOGI N.: Pulsed-exposure and postantibiotic leukocyte enhancement effect of amikacin, clarithromycin, clofazimine and rifampin against intracellular Mycobacterium avium. Antimicrob.Agents Chemother. 42, 3006-3008 (1998).
14. HOŠTACKÁ A.: Alterations in surface hydrophobicity of Acinetobacter baumannii induced by meropenem. Folia Microbiol. 44, 267-270 (1999).
15. HOŠTACKÁ A.: The in vitro effect of imipenem and ofloxacin on enzymic activity of Klebsiella strains. Folia Microbiol. 45, 387-390 (2000).
16. HYBENOVÁ D., MAJTÁN V.: The influence of postantibiotic effect and postantibiotic effect of subinhibitory concentrations of some quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa. Pharmazie 52, 157-159 (1997).
17. JONES R.N., BARRY A.L., THORNSBERRY C.: In-vitro studies of meropenem. J.Antimicrob.Chemother. 24 (Suppl. A), 9-29 (1989).
18. LABIA R., MORAND A., GUIONIE M.: β-Lactamase stability of imipenem. J.Antimicrob.Chemother. 18 (Suppl. E), 1-8 (1986).
19. LACHICA R.V., ZINK D.L.: Plasmid-associated cell surface charge and hydrophobicity of Yersinia enterocolitica. Infect.Immun. 44, 540-543 (1984).
20. LATRACHE H., BOURLIOUX P., KARROUA M., ZAHIR H., HAKKOU A.: Effects of subinhibitory concentrations of nitroxoline on the surface properties of Escherichia coli. Folia Microbiol. 45, 485-490 (2000).
21. LÖWDIN E., ODENHOLT-TORNQVIST I., BENGTSSON S., CARS O.: A new method to determine postantibiotic effect and effect of subinhibitory antibiotic concentrations. Antimicrob.Agents Chemother. 37, 2200-2205 (1993).
22. MACKENZIE F.M., GOULD I.M.: The postantibiotic effect. J.Antimicrob.Chemother. 32, 519-537 (1993).
23. MAJCHERCZYK P., LIVERMORE P.A.: Penicillin-binding protein (PBP) 2 and the postantibiotic effect of carbapenems. J.Antimicrob. Chemother 22, 75-79 (1990).
24. MAJTÁN V., HOŠTACKÁ A.: Influence of postantibiotic effect and postantibiotic sub-MICs of netilmicin, tobramycin, ciprotloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa. Folia Microbiol. 41, 228-232 (1996).
25. MAJTÁN V., MAJTÁNOVÁ L'.: Postantibiotic effect of some antibiotics on the metabolism of Pseudomonas aeruginosa. J.Basic Microbiol. 38, 221-227 (1998)
26. MAJTÁNOVÁ L'., MAJTÁN V.: Postantibiotic effect of imipenem and enoxacin against S. typhimurium and S. enteritidis and the influence on their surface hydrophobicity. Folia Microbiol. 43, 104-108 (1998a).
27. MAJTÁNOVÁ L'., MAJTÁN V.: Postantibiotic effect and postantibiotic sub-MICs effect of ciprotloxacin, pefloxacin, netilmicin and tobramycin on Enterobacter cloacae and their influence on hydrophobicity. Microbios 95, 155-164 (1998b).
28. MOELLERING R.C., ELIOPOULOS G.M. Jr., SENTOCHNIL D.E.: The carbapenems: new broad spectrum β-lactam antibiotics. J.Antimicrob.Chemother. 24 (Suppl. A), 1-7 (1989).
29. MOLINARI G., PAGLIA P., SCHITO G.C.: Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin. Eur.J.Clin.Microbiol.Infect.Dis. 11, 469-471 (1992).
30. NADLER H.I., PITKIN D.H., SHEIKH W.: The postantibiotic effect of meropenem and imipenem on selected bacteria. J.Antimicrob. Chemother. 24 (Suppl. A), 225-231 (1989).
31. NADLER H.I., SHEIKH W.: A comparison of the in vitro postantibiotic effect of meropenem and imipenem versus selected Enterobacteriaceae and other pathogens. Diagnos.Microbiol.Infec.Dis. 12, 171-175 (1993).
32. ODENHOLT-TORNQVIST I.: Studies on the postantibiotic effect and postantibiotic sub-MIC effect of meropenem. J.Antimicrob. Chemother. 31, 881-892 (1993).
33. ODENHOLT I., LÖWDIN E., CARS O.: Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria. Clin.Microbiol.Infectol. 3, 73-81 (1997).
34. PRUUL H., LEWIS G., MCDONALD P.J.: Enhanced susceptibility of Gram-negative bacteria to phagocytic killing by human polymorphonuclear leukocytes after brief exposure to aztreonam. J. Antimicrob.Chemother. 22, 675-686 (1988).
35. ROSENBERG M., GUTNICK D., ROSENBERG E.: Adherence of bacteria to hydrocarbons: a simple method for measuring cell-surface hydrophobicity. FEMS Microbiol.Let. 9, 29-33 (1980).
36. TANIO T., FUKASAWA M.: The in vitro postantibiotic effect of meropenem against Pseudomonas aeruginosa. Chemotherapy (Tokyo) 40 (Suppl. 1), 103-106 (1992).
37. TAWFIK A.F., RAMADAN M.A., SHIBL A.M.: Inhibition of motility and adherence of Proteus mirabilis to uroepithelial cells by subinhibitory concentrations of amikacin. Chemotherapy 43, 424-429 (1997).
38. ZHANEL G.G., CRAMPTON D.J., KINA S., NICOLLE L.E., DAVIDSON R.J., HOBAN D.J.: Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect. Chemotherapy 38, 388-394 (1992).